OTTAWA — Canada has pulled the plug on funding to one of the largest AIDS vaccine development agencies in the world.
Between 2001 and 2008, the Canadian International Development Agency contributed nearly $80 million to the International AIDS Vaccine Initiative, one of the biggest backers of HIV vaccine trials in the developing world. Canada was one of IAVI's major funders.
In 2009, Canada contributed nothing to the organization and said funding was under review. There was no money again in this year's federal budget and no decision on whether IAVI will ever receive Canadian funding again.Read more »
OTTAWA -- A Manitoba MP fears the reputation of the agency responsible for funding health research in Canada is in jeopardy after a House of Commons committee rejected her motion to try to quash the appointment of a drug company executive to the institute's board.The health committee Monday debated the qualifications of Dr. Bernard Prigent, vice-president and medical director of Pfizer Canada, to the governing council of the Canadian Institutes for Health Research. His appointment was announced by Health Minister Leona Aglukkaq in October but an outpouring of concern, including a petition with over 3,600 signatures, led the committee to take it upon itself to review Prigent's credentials.Read more »
A bill that would make it easier to sell cheap HIV drugs to developing countries has passed second reading in the House of Commons.
Members of Parliament voted 143-127 on Wednesday in favour of sending Bill C-393 to committee.
New Democrat MP Judy Wasylycia-Leis sponsored the bill, which is designed to reform Canada's five-year-old access-to-medicines law.
Under Bill C-9, passed in May 2004, generic drug makers in Canada must obtain a special licence each time they want to sell a cheaper, generic version of a patented medicine to a developing country. They also have to pay royalties on any such sales to the patent-holding drugmakers, and the licence is good for only two years.Read more »